CI Investments Inc
TGTX icon

CI Investments Inc’s TG Therapeutics TGTX Stock Holding History

CI Investments Inc’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-138
Closed -$5K – 1193
2025
Q3 		$5K Sell
138
-32
-19% -$1.05K ﹤0.01% 1262
2025
Q2 		$6K Sell
170
-1,787
-91% -$66.5K ﹤0.01% 1260
2025
Q1 		$77K Sell
1,957
-8
-0.4% -$269 ﹤0.01% 978
2024
Q4 		$59K Sell
1,965
-1,104
-36% -$31.7K ﹤0.01% 1019
2024
Q3 		$72K Buy
3,069
+23
+0.8% +$502 ﹤0.01% 943
2024
Q2 		$54K Sell
3,046
-228
-7% -$3.64K ﹤0.01% 961
2024
Q1 		$50K Buy
3,274
+3
+0.1% +$48 ﹤0.01% 1021
2023
Q4 		$56K Buy
3,271
+1,135
+53% +$13.2K ﹤0.01% 953
2023
Q3 		$18K Sell
2,136
-64
-3% -$892 ﹤0.01% 1108
2023
Q2 		$55K Sell
2,200
-6,794
-76% -$175K ﹤0.01% 936
2023
Q1 		$135K Sell
8,994
-116
-1% -$1.76K ﹤0.01% 668
2022
Q4 		$108K Buy
9,110
+6,760
+288% +$49.1K ﹤0.01% 727
2022
Q3 		$14K Sell
2,350
-175
-7% -$1.15K ﹤0.01% 1096
2022
Q2 		$11K Buy
2,525
+1,503
+147% +$9.38K ﹤0.01% 1034
2022
Q1 		$10K Buy
+1,022
New +$11.8K ﹤0.01% 1088
2021
Q4 		– Sell
-7
Closed – – 1438
2021
Q3 		$0 Buy
+7
New +$217 ﹤0.01% 1390

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

CI Investments Inc's TGTX Position: Q4 2025 in Review

CI Investments Inc sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 138 shares — an estimated $5K sold.

CI Investments Inc first reported a position in TGTX in Q3 2021 and held it in 16 quarters. The position peaked at $135K in Q1 2023. 352 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • CI Investments Inc reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 138 TG Therapeutics shares in Q4 2025, an estimated $5K.
  • CI Investments Inc first reported a position in TG Therapeutics in Q3 2021 and held it in 16 quarters.
  • CI Investments Inc's TG Therapeutics position peaked at $135K in Q1 2023.
  • 352 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.